Screener
Climb Bio, Inc. CLYM Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Climb Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The source filing: Climb Bio, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 7:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210357
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Total operating expenses | 15,211 | 23,018 |
| Loss from operations | (15,211) | (23,018) |
| Other income (expense): | ||
| Interest income | 1,514 | 2,287 |
| Foreign currency (loss) | (25) | (50) |
| Total other income, net | 1,489 | 2,237 |
| Net loss | $(13,722) | $(20,781) |
| Net loss per share, basic and diluted | $(0.20) | $(0.31) |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Climb Bio, Inc.'s interest income?
- Climb Bio, Inc. (CLYM) reported interest income of $1.51M in Q1 2026.
- How has Climb Bio, Inc.'s interest income changed year-over-year?
- Climb Bio, Inc.'s interest income decreased by 33.8% year-over-year, from $2.29M to $1.51M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.
Ask your AI about Climb Bio, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude